Imunon, Inc. (IMNN)
1.58
-0.02
(-1.25%)
USD |
NASDAQ |
Sep 02, 16:00
1.58
0.00 (0.00%)
After-Hours: 19:41
Imunon Research and Development Expense (TTM) : 8.191M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.191M |
| March 31, 2026 | 7.953M |
| December 31, 2025 | 7.781M |
| September 30, 2025 | 7.524M |
| June 30, 2025 | 8.918M |
| March 31, 2025 | 10.51M |
| December 31, 2024 | 11.64M |
| September 30, 2024 | 12.96M |
| June 30, 2024 | 11.65M |
| March 31, 2024 | 11.96M |
| December 31, 2023 | 11.29M |
| September 30, 2023 | 10.74M |
| June 30, 2023 | 11.17M |
| March 31, 2023 | 11.26M |
| December 31, 2022 | 11.73M |
| September 30, 2022 | 11.72M |
| June 30, 2022 | 11.78M |
| March 31, 2022 | 11.14M |
| December 31, 2021 | 10.62M |
| September 30, 2021 | 10.44M |
| June 30, 2021 | 10.47M |
| March 31, 2021 | 10.86M |
| December 31, 2020 | 11.34M |
| September 30, 2020 | 11.60M |
| June 30, 2020 | 12.78M |
| Date | Value |
|---|---|
| March 31, 2020 | 13.35M |
| December 31, 2019 | 13.07M |
| September 30, 2019 | 12.34M |
| June 30, 2019 | 10.86M |
| March 31, 2019 | 11.89M |
| December 31, 2018 | 11.87M |
| September 30, 2018 | 12.73M |
| June 30, 2018 | 13.89M |
| March 31, 2018 | 12.34M |
| December 31, 2017 | 13.08M |
| September 30, 2017 | 13.49M |
| June 30, 2017 | 14.37M |
| March 31, 2017 | 14.66M |
| December 31, 2016 | 14.62M |
| September 30, 2016 | 14.71M |
| June 30, 2016 | 13.36M |
| March 31, 2016 | 13.59M |
| December 31, 2015 | 14.66M |
| September 30, 2015 | 15.24M |
| June 30, 2015 | 16.98M |
| March 31, 2015 | 16.58M |
| December 31, 2014 | 14.97M |
| September 30, 2014 | 12.56M |
| June 30, 2014 | 10.20M |
| March 31, 2014 | 9.054M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Phio Pharmaceuticals Corp. | 8.533M |
| Agenus, Inc. | 57.69M |
| Amgen, Inc. | 7.638B |
| Anika Therapeutics, Inc. | 27.45M |
| BioCryst Pharmaceuticals, Inc. | 195.46M |